S4.

Annual indirect cost of sampled former stomach and esophageal cancer patients by area ($)

Variable	Stomach cancer				Esophageal cancer
	All areas	Urban areas	Rural areas		All areas	Urban areas	Rural areas
*, clinical stage information of 519 patients was not reported; **, pathologic type information of 77 cases was not reported.
All	879	1,398	686		738	1,102	610
Sex
Male	834	1,364	675		776	1,100	613
Female	987	1,451	716		633	1,129	605
Age
Non-elderly	942	1,303	716		780	1,131	556
Elderly	831	1,549	668		721	1,080	627
Clinical stage*
I	795	1,279	584		689	1,074	525
II	844	986	798		483	536	464
III	1,136	2,055	769		1,166	1,810	852
IV	1,302	1,568	1,142		1,053	1,268	957
Pathologic type**
Adenocarcinoma	937	1,315	800		1,086	1,610	897
Squamous cell carcinoma	−	−	−		848	1,136	720
Other	712	1,648	287		367	786	295
Treatment
Surgery	664	1217	353		544	1,136	292
Radiotherapy	595	−	595		914	501	942
Chemotherapy	1,189	1,906	1,008		954	1,255	732
Concurrent chemoradiotherapy	2,994	4,576	1,555		1,014	1,001	1,018
Palliative care	855	785	868		885	746	914